250 related articles for article (PubMed ID: 29172532)
41. Curcumin-loaded N,O-carboxymethyl chitosan nanoparticles for cancer drug delivery.
Anitha A; Maya S; Deepa N; Chennazhi KP; Nair SV; Jayakumar R
J Biomater Sci Polym Ed; 2012; 23(11):1381-400. PubMed ID: 21722423
[TBL] [Abstract][Full Text] [Related]
42. Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles.
Pan L; Zhang Z; Lv J; Zhou P; Hu W; Fang Y; Chen H; Liu X; Shao J; Zhao F; Ding Y; Lin T; Chang H; Zhang J; Zhang Y; Wang Y
Int J Nanomedicine; 2014; 9():5603-18. PubMed ID: 25506214
[TBL] [Abstract][Full Text] [Related]
43. Chitosan derivative composite nanoparticles as adjuvants enhance the cellular immune response via activation of the cGAS-STING pathway.
Zhao Z; Peng Y; Shi X; Zhao K
Int J Pharm; 2023 Apr; 636():122847. PubMed ID: 36933583
[TBL] [Abstract][Full Text] [Related]
44. Bicistronic DNA vaccine macromolecule complexed with poly lactic-co-glycolic acid-chitosan nanoparticles enhanced the mucosal immunity of Labeo rohita against Edwardsiella tarda infection.
Leya T; Ahmad I; Sharma R; Tripathi G; Kurcheti PP; Rajendran KV; Bedekar MK
Int J Biol Macromol; 2020 Aug; 156():928-937. PubMed ID: 32289420
[TBL] [Abstract][Full Text] [Related]
45. Cordyceps militaris polysaccharides can improve the immune efficacy of Newcastle disease vaccine in chicken.
Wang M; Meng X; Yang R; Qin T; Li Y; Zhang L; Fei C; Zhen W; Zhang K; Wang X; Hu Y; Xue F
Int J Biol Macromol; 2013 Aug; 59():178-83. PubMed ID: 23587997
[TBL] [Abstract][Full Text] [Related]
46. Effect of the cagW-based gene vaccine on the immunologic properties of BALB/c mouse: an efficient candidate for Helicobacter pylori DNA vaccine.
Chehelgerdi M; Doosti A
J Nanobiotechnology; 2020 Apr; 18(1):63. PubMed ID: 32316990
[TBL] [Abstract][Full Text] [Related]
47. Nebulized anionic guanidinylated O-carboxymethyl chitosan/N-2-hydroxypropyltimehyl ammonium chloride chitosan nanoparticles for siRNA pulmonary delivery: preparation, characterization and in vitro evaluation.
Ni S; Xie Y; Tang Y; Liu Y; Chen J; Zhu S
J Drug Target; 2017 Jun; 25(5):451-462. PubMed ID: 28110554
[TBL] [Abstract][Full Text] [Related]
48.
Zhao K; Gao Y; Hu G; Wang L; Cui S; Jin Z
Vaccines (Basel); 2021 Sep; 9(9):. PubMed ID: 34579264
[TBL] [Abstract][Full Text] [Related]
49. Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate/chitosan nanoparticles induces protection against highly pathogenic influenza A virus.
Moon HJ; Lee JS; Talactac MR; Chowdhury MY; Kim JH; Park ME; Choi YK; Sung MH; Kim CJ
Vet Microbiol; 2012 Dec; 160(3-4):277-89. PubMed ID: 22763171
[TBL] [Abstract][Full Text] [Related]
50. Mucoadhesive glycol chitosan nanoparticles for intranasal delivery of hepatitis B vaccine: enhancement of mucosal and systemic immune response.
Pawar D; Jaganathan KS
Drug Deliv; 2016; 23(1):185-94. PubMed ID: 24825494
[TBL] [Abstract][Full Text] [Related]
51. Adenoviral-expressed recombinant granulocyte monocyte colony-stimulating factor (GM-CSF) enhances protective immunity induced by inactivated Newcastle Disease Virus (NDV) vaccine.
Wang X; Wang X; Jia Y; Wang C; Han Q; Lu ZH; Yang Z
Antiviral Res; 2017 Aug; 144():322-329. PubMed ID: 28698014
[TBL] [Abstract][Full Text] [Related]
52. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
[TBL] [Abstract][Full Text] [Related]
53. [Cloning of F gene of Newcastle disease virus HeB02 isolate and the study of its DNA vaccine].
Li N; Sun YM; Zhao BH
Sheng Wu Gong Cheng Xue Bao; 2006 May; 22(3):445-50. PubMed ID: 16755925
[TBL] [Abstract][Full Text] [Related]
54. Effects of pidotimod soluble powder and immune enhancement of Newcastle disease vaccine in chickens.
Qu S; Dai C; Qiu M; Zhang R; Wang C; Cui L; Hao Z
Immunol Lett; 2017 Jul; 187():14-18. PubMed ID: 28487096
[TBL] [Abstract][Full Text] [Related]
55. Improved protection from velogenic Newcastle disease virus challenge following multiple immunizations with plasmid DNA encoding for F and HN genes.
Loke CF; Omar AR; Raha AR; Yusoff K
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):259-67. PubMed ID: 15963824
[TBL] [Abstract][Full Text] [Related]
56. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
Gupta NK; Tomar P; Sharma V; Dixit VK
Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
[TBL] [Abstract][Full Text] [Related]
57. Sulfated glucan can improve the immune efficacy of Newcastle disease vaccine in chicken.
Wang M; Yang R; Zhang L; Meng X; Fei C; Zhang K; Wang X; Zheng W; Xiao S; Zhang S; Xue F; Hu Y
Int J Biol Macromol; 2014 Sep; 70():193-8. PubMed ID: 24875318
[TBL] [Abstract][Full Text] [Related]
58. Amidase encapsulated O-carboxymethyl chitosan nanoparticles for vaccine delivery.
Smitha KT; Sreelakshmi M; Nisha N; Jayakumar R; Biswas R
Int J Biol Macromol; 2014 Feb; 63():154-7. PubMed ID: 24211432
[TBL] [Abstract][Full Text] [Related]
59. Development of PLGA-PEG-PLGA Hydrogel Delivery System for Enhanced Immunoreaction and Efficacy of Newcastle Disease Virus DNA Vaccine.
Gao Y; Ji H; Peng L; Gao X; Jiang S
Molecules; 2020 May; 25(11):. PubMed ID: 32481518
[TBL] [Abstract][Full Text] [Related]
60. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus.
Wang X; Zhang X; Kang Y; Jin H; Du X; Zhao G; Yu Y; Li J; Su B; Huang C; Wang B
Vaccine; 2008 Sep; 26(40):5135-44. PubMed ID: 18462848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
